Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Key Cannabis Analyst Names Green Thumb Top Pick For 2021

By (Brenda O'Farrell/ MarketsApr 27, 2021 10:57
Key Cannabis Analyst Names Green Thumb Top Pick For 2021
By (Brenda O'Farrell/   |  Apr 27, 2021 10:57
Saved. See Saved Items.
This article has already been saved in your Saved Items

One of the best known analysts covering marijuana stocks is Vivien Azer, a managing director with Cowen. She has been watching the cannabis industry since 2016, which is before legalisation in Canada. Today, her firm offers analysis of not only Canadian, but US and global firms in the space and insights into the CBD market.

In an interview recently, she was asked about her top stock pick in the space: Green Thumb Industries (OTC:GTBIF) (CSE:GTII).

Azer likes this Chicago-based cultivator because, as she explained, it is one of only 10 companies that hold cannabis licences in New York State, which is on the verge of being a multi-billion cannabis market.

Green Thumb Daily
Green Thumb Daily

Shares of Green Thumb have done relatively well in 2021, gaining about 12.5% since the start of the year. In the last 12 months, however, they have increased by almost 300%. Shares were up 0.29% yesterday, and closed at $28.50 in New York and C$35.50 on the Toronto Stock Exchange.

What Azer likes about the company are its profitability and what she calls its “geographic mix,” referring to the states in which it operates.

Its strategy has been focused on developing in states with large populations and a limited number of cannabis growing licences. This includes Illinois, Massachusetts, New York, Florida and Ohio. And so far this approach has worked well, as two of these relatively large markets—Illinois and Massachusetts—have moved from allowing purely medical use of cannabis to a combination of medical and recreational use.

Green Thumb is set to reveal its first-quarter earnings results on May 12, after the close.

In Q4, its revenues increased almost 13%. For the full year, its revenues hit $556.6 million for a year-over-year gain of just over 157%.

The last quarter also represented the fourth consecutive quarter of positive cash flow from operations.

This strong balance sheet is another reason Azer likes the stock.

Cannabis Derivatives Sales Fastest Growing Segment In Canadian Market

The first full-year look at the size of the Canadian cannabis derivatives market are in, and the figures are sending an upbeat signal to the industry.

Canadians purchased C$109 million (US$87.8 million) worth of cannabis edibles in 2020, according to Statistics Canada.

Although that figure only represents a small fraction (4.2%) of the legal cannabis sales, these numbers are encouraging as inventory and product selection are expected to improve.

The important metric being eyed is the fact that growth in cannabis edibles was more significant the rest of the overall marijuana industry, according to StatsCan figures.

Canada’s regulated recreational cannabis market in 2020 was said to be C$2.6 billion. The largest part of that, just over three-quarters, came from dried cannabis sales.

One analyst said the mix of sales in Canada is very similar to what was seen in Colorado in the early stages of legalization, leading to speculation that derivative products could eventually represents about 50% of the Canadian market. Availability of cannabis-infused beverages and edibles are still relatively limited in accessibility.

Tilray Vote Rules Change

The long-awaited vote by Tilray (NASDAQ:TLRY) stockholders to approve the proposed merger with Aphria (NASDAQ:APHA) (TSX:APHA) is now expected to be held on Friday, Apr. 30.

One day after it was announced that the vote was delayed to give shareholders more time, the cannabis grower amended its bylaws to reduce its quorum requirement. The vote was originally scheduled for Apr. 16. The new quorum requirement has been lowered to 33% of shareholders, down from the previous threshold of 50%-plus-1.

Shareholders who already cast votes will not have to vote again.

Analysts have speculated that the company’s shareholder base includes many retail investors, which makes share ownership turnover more volatile.

Earlier this month, Aphria shareholders overwhelmingly voted to approve the merger deal with just over 99% of votes cast. The companies announced the US$3.9-billion (C$5-billion) merger deal in December. The new combined company, which will trade under the Tilray ticker, will be the biggest cannabis grower in the world.

Key Cannabis Analyst Names Green Thumb Top Pick For 2021

Related Articles

Key Cannabis Analyst Names Green Thumb Top Pick For 2021

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Jason Rich
Jason Rich Apr 27, 2021 22:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Green Thumb hmm someone may have green something ... lots of things to like ... but does it stack up to £7.5bn? With less than £1bn NAV and priced at nearly 400 x earnings? So many competitors and new entrants ... the market is growing in all directions but you’d have to be high to put this one up top ... that said there will be so many mergers you’d best have a piece of everything
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email